ImmunityBio Inc.

NASDAQ: IBRX · Real-Time Price · USD
2.54
-0.17 (-6.27%)
At close: Aug 15, 2025, 3:59 PM
2.55
0.20%
After-hours: Aug 15, 2025, 05:47 PM EDT

ImmunityBio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
143.43M 265.45M 104.64M 181.1M
Short-Term Investments
6.38M 1.01M 2.54M 136.01M
Long-Term Investments
8.31M 891K 5.7M 6.78M
Other Long-Term Assets
3.64M 9.7M 6.63M 7.2M
Receivables
2.65M 3.17M 1.89M 1.33M
Inventory
8.27M n/a 26.35M n/a
Other Current Assets
2.55M 5.21M 5.15M 5.55M
Total Current Assets
184.59M 294.08M 140.58M 334.35M
Property-Plant & Equipment
170.46M 182.68M 189.45M 119.17M
Goodwill & Intangibles
15.93M 17.09M 20M 1.42M
Total Long-Term Assets
198.35M 210.37M 221.78M 134.56M
Total Assets
382.93M 504.45M 362.36M 468.91M
Account Payables
6.72M 9.2M 21.02M 11.42M
Deferred Revenue
100K n/a 100K n/a
Short-Term Debt
1.25M n/a 431.9M 302.25M
Other Current Liabilities
1.5M 18.31M 19.74M 46.71M
Total Current Liabilities
54.94M 58.28M 500.86M 369M
Long-Term Debt
746.28M 681.54M 241.27M 343.42M
Other Long-Term Liabilities
35.01M 310.63M 22.09M -36.82M
Total Long-Term Liabilities
816.12M 1.03B 311.31M 343.83M
Total Liabilities
871.06M 1.09B 812.18M 712.82M
Total Debt
504.17M 726.72M 723.77M 645.66M
Common Stock
85K 67K 42K 40K
Retained Earnings
-3.38B -2.96B -2.38B -1.96B
Comprehensive Income
1.2M 10K 183K 4K
Shareholders Equity
-488.13M -586.99M -447.33M -242.17M
Total Investments
6.38M 1.9M 8.24M 142.79M